Neuropeptide Y Y 1 receptors are involved in the vasoconstriction caused by human sympathetic nerve stimulation

By Racchi H.   Schliem A.J.   Donoso M.V.   Rahmer A.   Zuniga A.   Guzman S.   Rudolf K.   Huidobro-Toro J.P.  

European Journal of Pharmacology, Vol. 329, Iss. 1, 1997-06 ,pp. : 79-83

Elsevier

Access to resources Recommend Favorite

Pharmacology of H 394/84, a dihydropyridine neuropeptide Y Y 1 receptor antagonist, in vivo

By Malmstrom R.E.   Balmer K.C.   Weilitz J.   Nordlander M.   Sjolander M.  

European Journal of Pharmacology, Vol. 418, Iss. 1, 2001-04 ,pp. : 95-104

Elsevier

Access to resources Recommend Favorite

Neuropeptide Y accounts for sympathetic vasoconstriction in guinea-pig vena cava: evidence using BIBP 3226 and 3435

By Malmstrom R.E.   Lundberg J.M.  

European Journal of Pharmacology, Vol. 294, Iss. 2, 1995-12 ,pp. : 661-668

Elsevier

Access to resources Recommend Favorite

Neuropeptide Y receptor antagonists

By Ling A.L.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 4, 1999-04 ,pp. : 375-384

Informa Healthcare

Access to resources Recommend Favorite

Neuropeptide Y potentiates noradrenaline-induced contraction through the neuropeptide Y Y 1 receptor

By Bergdahl A.   Nilsson T.   Cantera L.   Nilsson L.   Xiang-Ying S.   Hedner T.   Erlinge D.   Valdemarson S.   Edvinsson L.  

European Journal of Pharmacology, Vol. 316, Iss. 1, 1996-11 ,pp. : 59-64

Elsevier

Access to resources Recommend Favorite